Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

453 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Induction chemotherapy followed by concurrent chemotherapy and definitive high-dose radiotherapy for patients with locally advanced non-small-cell lung cancer (stages IIIa/IIIb): a pilot phase I/II trial.
Pöttgen C, Eberhardt W, Bildat S, Stüben G, Stamatis G, Hillejan L, Sohrab S, Teschler H, Seeber S, Sack H, Stuschke M. Pöttgen C, et al. Among authors: eberhardt w. Ann Oncol. 2002 Mar;13(3):403-11. doi: 10.1093/annonc/mdf050. Ann Oncol. 2002. PMID: 11996471 Free article. Clinical Trial.
Phase I/II study with a weekly 24-hour infusion of 5-fluorouracil plus high-dose folinic acid (HD-FU/FA) in intensively pretreated patients with metastatic breast cancer.
Wilke H, Klaassen U, Achterrath W, Losch M, Vanhoefer U, Hayungs J, Harstrick A, Stahl M, Eberhardt W, Becher R, Seeber S. Wilke H, et al. Among authors: eberhardt w. Ann Oncol. 1996 Jan;7(1):55-8. doi: 10.1093/oxfordjournals.annonc.a010478. Ann Oncol. 1996. PMID: 9081392 Free article. Clinical Trial.
Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial.
Eberhardt W, Wilke H, Stamatis G, Stuschke M, Harstrick A, Menker H, Krause B, Müeller MR, Stahl M, Flasshove M, Budach V, Greschuchna D, Konietzko N, Sack H, Seeber S. Eberhardt W, et al. J Clin Oncol. 1998 Feb;16(2):622-34. doi: 10.1200/JCO.1998.16.2.622. J Clin Oncol. 1998. PMID: 9469351 Clinical Trial.
453 results